Medicine Supply Notification: Rivastigmine 4.6mg/24hours and 9.5mg/24hours transdermal patches – updated
Update 04/06/2026: Changes in the alert below are in bold Update 08/01/2026: Alzest transdermal patches (Dr Reddy’s Laboratories (UK) Ltd) in all strengths have been discontinued. Please note: Care is needed if switching between daily and twice weekly (Zeyzelf) rivastigmine patches to avoid the risk of dosing error. The Department of Health and Social Care (DHSC) [...]
The post Medicine Supply Notification: Rivastigmine 4.6mg/24hours and 9.5mg/24hours transdermal patches – updated appeared first on Community Pharmacy England.
Important: This alert is aggregated automatically for information only.
Always refer to the original source and follow your practice's own clinical governance procedures.
Get the weekly digest — all new alerts summarised and delivered to your NHS inbox every Monday.
View this week's digest